Non-cystic Fibrosis Bronchiectasis Treatment 2021 | Prominent Players, Pipeline Growth, Future Trends, Unmet Demands, Emerging Therapies: DelveInsight

NEXT STORY
Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai
PREV STORY
How Do You Define Value in Healthcare?
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Independence Blue Cross and Thomas Jefferson University launch medical research program, latest initiative of their Collaboration to improve healthcare quality and lower costs

PHILADELPHIA, March 2, 2016 (GLOBE NEWSWIRE) -- Independence Blue Cross (Independence) and Thomas Jefferson ...

author_avatar
NASDAQ Market News

Argos Therapeutics Announces Appointment of Richard Morrison, PhD to Board of Directors

DURHAM, N.C., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology ...

author_avatar
NASDAQ Market News

VBL Therapeutics Announces Patient Dosing Initiated in Randomized, Controlled and Blinded Trial of VB-111 in Patients with Recurrent Glioblastoma Multiforme

author_avatar
NASDAQ Market News